Hot keywords:Tobramycin sulfate injection / bupivacaine hydrochloride injection / amlodipine besylate tablets / bupivacaine hydrochloride injection

PRODUCTS

产品展示

PRODUCTS

产品展示

COOPERATIVE PARTNER

COOPERATIVE PARTNER

关于我们

ABOUT US

ABOUT US

关于我们

Anhui Changjiang Pharmaceutical Co., Ltd. is located in Wuhu, Anhui Province, which is a beautiful and rich "giant port of the Yangtze River and the backbone of Anhui Province". Wuhu is located in the northwest of the Yangtze River Delta, with superior geographical position, adjacent to the river and offshore, connecting the East with the west, connecting the South with the north, with convenient transportation and beautiful environment. Wuhu is also an important comprehensive transportation hub in China. Wuhu port, with the fifth largest port in the Yangtze River, is the larger foreign trade terminal in Anhui Province.
Time of establishment: December 2001
Registered address: No.152, Changjiang South Road, high tech Development Zone, Yijiang District, Wuhu City, Anhui Province

Tel: 0553-2245066 (domestic sales) 0553-2245055 (export sales)

Scope of business: production of tablets, small volume injections (including hormone), psychotropic drugs, and import and export business of various commodities and technologies.

Registered capital: 128 million yuan

......

NEWS

NEWS

The enterprise image of "science and technology dedication, true feelings, quality achievements and health" is the strategy to accelerate the development of enterprises

DEVELOPMENT HISTORY

DEVELOPMENT HISTORY

  • 1954
  • 2001
  • 2002
  • 2006
  • 2008
  • 2013
  • 2014
  • 2016
  • 2019

Anhui Changjiang pharmaceutical factory (state-owned enterprise, established in 1954)

The current director, Mr. Guilin, restructured and reorganized the company

Three dosage forms of the company passed national GMP certification at one time

The enterprise technology research center has been set up, and the foreign trade has obtained the independent export right

Anhui Province "pharmaceutical production management, efficiency" double excellent "enterprises and national" high tech enterprises "

The new version of GMP I was approved in March

In March, Shuizhen II workshop passed the national new GMP certification

In August, the solid workshop passed the national new GMP certification

In July, the company was renamed Anhui Changjiang Pharmaceutical Co., Ltd

MARKETING STRATEGY

1. Protection of existing products and key products;
2. We should use modern marketing concept to open up new product market and promote the whole marketing process of key products with humanistic concept;
3. Increase the promotion of new drug varieties with market potential, and completely reverse the situation of lack of follow-up products and short product line;
4、Actively seek multi-channel cooperation to increase the market competitiveness and added value of traditional varieties;

BUSINESS SITUATION

Domestic market accounts for 60% 

At present, 24 provinces and cities in China have established sales networks and participated in bidding, and the products have been sold by pharmaceutical companies. Among them, East China and central China are the main markets

Export 30%

It has been registered in more than 20 overseas countries and regions, mainly to Eastern Europe, South America, Africa, the Middle East and Southeast Asia

Cooperative production 10%

It has successively cooperated with well-known domestic pharmaceutical enterprises, including Shanghai Pharmaceutical Group, China Resources medicine, JIUZHOUTONG Pharmaceutical Group, etc